deLIVER: Direct Acting Antiviral Effects on the Liver

Trial Profile

deLIVER: Direct Acting Antiviral Effects on the Liver

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Jan 2018

At a glance

  • Drugs Sofosbuvir/velpatasvir (Primary) ; Sofosbuvir/velpatasvir/voxilaprevir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms deLIVER
  • Most Recent Events

    • 22 Dec 2017 Status changed from recruiting to active, no longer recruiting.
    • 07 Apr 2017 Status changed from not yet recruiting to recruiting.
    • 25 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top